-
BTIG Buys Into Globus Medical's Longer-Term Vision
Wednesday, March 18, 2020 - 3:28pm | 382Read More...Globus Medical Inc’s (NYSE: GMED) shares have declined around 33% from their year-end 2019 high, and the company has a strong balance sheet that can be used to acquire assets at depressed values, according to BTIG. The Globus Medical Analyst BTIG’s Ryan Zimmerman upgraded...
-
BTIG Downgrades Orthofix Medical On M6 Uncertainty
Tuesday, February 26, 2019 - 12:22pm | 343Read More...Orthofix Medical Inc (NASDAQ: OFIX) reported quarterly results Monday that were broadly in-line with expectations while guiding to higher spending and linear revenue growth. Investors can look past the guidance and the announcement of CEO Brad Mason's retirement during a...
-
BTIG Sees Limited Upside For Globus Medical, Downgrades To Neutral
Monday, April 16, 2018 - 3:46pm | 285Read More...Globus Medical Inc (NYSE: GMED) is up 64 percent year-over-year, but it may be exhausting its potential. The Rating BTIG analyst Ryan Zimmerman downgraded Globus Medical to Neutral. The Thesis Globus Medical is seen to have ridden intensified investor interest in robotics, which compounded...
-
Analyst On Endologix: No Sense In Downgrading Now
Thursday, May 18, 2017 - 10:45am | 593Read More...Endologix, Inc. (NASDAQ: ELGX) announced on Thursday after the market close that it needs to conduct a confirmatory clinical trial for its Nellix Endovascular Aneurysm Sealing System with the previously updated instructions for use and the Gen2 device design. This follows the company's meeting...
